Stronger Sell Today ACRX ranks #3505 as SELL CANDIDATE #3505 Weaker Sell

ACRX stock forecast AcelRx Pharmaceuticals

ACRX stock forecast

Friday January 17, 2020 Change -4.52% Price $1.90
Your prediction: Prediction: Request
VOLUME
Buy
TREND
Buy
MV LONG
Sell

MV SHORT
Sell

PIVOT
Sell

MACD
Sell
Bullish vs. Bearish (21 opinions)
71%
29%
Social Sentiment 0.06

ACRX Forecast and Technical Stock Analysis


Sell candidate since 2020-01-16 Loss -4.52% PDF

AcelRx Pharmaceuticals fell by -4.52% in the last day ( Friday, 17th Jan 2020 ) from $1.99 to $1.90 During the day the stock fluctuated 5.26% from a day low at $1.90 to a day high of $2.00. The price has fallen in 6 of the last 10 days and is down by -6.86% for this period. Volume has increased in the last day by 65 434 shares but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 687 168 shares bought and sold for approximately $1.31 million.

Quick summary:

  • 30 day high of the ACRX stock price was $2.44 and low was $1.83.
  • 90 day high was $2.50 and low was $1.64.
  • 52 week high for AcelRx Pharmaceuticals - $4.09 and low - $1.64.
Top Trending Stocks

Trend

AcelRx Pharmaceuticals lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 2.67% during the next 3 months and, with 90% probability hold a price between $1.74 and $2.48 at the end of this period.

Top Golden Star Stocks

Signals

There are few to none technical positive signals at the moment. AcelRx Pharmaceuticals holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $1.95 and $2.06. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Thursday January 16, 2020, which indicates further falls until a new bottom pivot has been found. AcelRx Pharmaceuticals gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSImin/max Values: [ 25 - 75 ]

The stock currently holds a RSI14 at 23 and is oversold on RSI14. The stock being oversold is no guarantee for instant reaction up as some stocks may be oversold for a long time. It is important to review the previous RSI-history to get an indication of the RSI-sensitiveness.

* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.

Support & Resistance

On the downside, the stock finds support just below today's level from accumulated volume at $1.78 and $1.76.

There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, AcelRx Pharmaceuticals finds support just below today's level at $1.78. If this is broken, then the next support from accumulated volume will be at $1.76 and $1.66.

Support: $1.78 Price: $1.90 Resistance: $2.00

Risk

This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.10 between high and low, or 5.26%. For the last week, the stock has had a daily average volatility of 4.65%.

AcelRx Pharmaceuticals is oversold on RSI14 (23). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a sell evaluation for this stock. No stop-loss set.

4.65 %

Average volatility

Overall risk:

Very Low Low Medium High Very High

Sell Candidate Upgraded

Evaluation

The AcelRx Pharmaceuticals stock holds several negative signals and despite the positive trend we believe AcelRx Pharmaceuticals will perform weak in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Stronger Sell Today ACRX ranks #3505 as SELL CANDIDATE #3505 Weaker Sell
Exchange: NASDAQ | NYSE | XLON | AMS | TSX | BRU

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

Proudly Made At

ROCKIT